Inventor · disambiguated record
John M. Peterson
Also filed as: PETERSON JOHN · PETERSON JOHN M · PETERSON JOHN MATTHEW
34 granted patents·28 pending applications·353 citations·filing 1995–2023
97Inventor score
Top patents by PatentIndex Score
62 records- 0191US6723743B1High affinity small molecule C5a receptor modulatorsNEUROGEN CORP·Filed 2000·Granted Apr 20, 2004·32 cites·44 claims
- 0287US11780873B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Oct 10, 2023·1 cites·42 claims
- 0387US7253168B2Substituted 1-benzyl-4-substituted piperazine analoguesNEUROGEN CORP·Filed 2005·Granted Aug 7, 2007·13 cites·26 claims
- 0487US6069251ACertain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4- substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1997·Granted May 30, 2000·25 cites·9 claims
- 0586US11072625B2Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2017·Granted Jul 27, 2021·4 cites·35 claims
- 0685US5712392ACertain 4-piperidine- and piperazinoalkyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Jan 27, 1998·21 cites·4 claims
- 0784US6316617B1Certain amido-and amino-substituted benzylamine derivatives; a new class of Neuropeptide Y1 specific ligandsNEUROGEN CORP·Filed 2000·Granted Nov 13, 2001·17 cites·16 claims
- 0883US7160879B2Melanin concentrating hormone receptor ligands: substituted 2-(4-benzyl-piperazin-1-ylmethyl)- and 2-(4-benzyl-diazepan-1-ylmethyl)-1H-benzoimidazole analoguesNEUROGEN CORP·Filed 2003·Granted Jan 9, 2007·26 cites·24 claims
- 0983US5633377A4-piperidino- and piperazinomethyl-2-cyclohexyl imidazole derivatives; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted May 27, 1997·18 cites·4 claims
- 1082US10519181B2Heterobifunctional inhibitors of E-selectins and CXCR4 chemokine receptorsGLYCOMIMETICS INC·Filed 2015·Granted Dec 31, 2019·4 cites·31 claims
- 1182US7728009B1Thiazole amides, imidazole amides and related analoguesNEUROGEN CORP·Filed 2006·Granted Jun 1, 2010·6 cites·18 claims
- 1280US6884815B1High affinity small molecule C5a receptor modulatorsNEUROGEN CORP·Filed 2003·Granted Apr 26, 2005·9 cites·48 claims
- 1380US6358949B1Aryl and hetroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptorsNEUROGEN CORP·Filed 2000·Granted Mar 19, 2002·10 cites·56 claims
- 1479US11197877B2Galactopyranosyl-cyclohexyl derivauves as E-selectin antagonistsGLYCOMIMETICS INC·Filed 2018·Granted Dec 14, 2021·2 cites·53 claims
- 1579US6953801B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2002·Granted Oct 11, 2005·11 cites·30 claims
- 1679US6703393B2(Oxo-pyrazolo[1,5a]pyrimidin-2-yl) alkyl-carboxamidesNEUROGEN CORP·Filed 2002·Granted Mar 9, 2004·11 cites·68 claims
- 1778US6358955B1Substituted imidazoles as subtype specific dopamine receptor ligands and pharmaceutical compositions containing such substituted imidazoleNEUROGEN CORP·Filed 2000·Granted Mar 19, 2002·5 cites·21 claims
- 1878US5962455ACertain substituted benzylamine derivatives a new class of neuropeptide Y1 specific ligandsNEUROGEN CORP·Filed 1997·Granted Oct 5, 1999·44 cites·11 claims
- 1978US2024165139A1Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2077US6797824B2Certain 4-aminomethyl-2-substituted imidazole derivatives and 2-aminomethyl-4-substituted imidazole derivatives; new classes of dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 2002·Granted Sep 28, 2004·4 cites·4 claims
- 2177US6420365B1Imidazopyridines and related derivatives as selective modulators of bradykinin B2 receptorsNEUROGEN CORP·Filed 2001·Granted Jul 16, 2002·9 cites·40 claims
- 2276US2023365609A1Highly potent multimeric e-selectin antagonistsGLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 2375US7851474B2Dipiperazinyl ketones and related analoguesNEUROGEN CORP·Filed 2006·Granted Dec 14, 2010·3 cites·22 claims
- 2475US6133265ACertain amido- and amino- substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligandsNEUROGEN CORP·Filed 1997·Granted Oct 17, 2000·33 cites·20 claims
- 2574US11845771B2Heterobifunctional inhibitors of E-selectin and galectin-3GLYCOMIMETICS INC·Filed 2019·Granted Dec 19, 2023·1 cites·61 claims
- 2674US5900415ACertain substituted benzylamine derivatives; a new class of neuropeptide Y1 specific ligandsPFIZER·Filed 1995·Granted May 4, 1999·14 cites·8 claims
- 2773US11878026B2Galactopyranosyl-cyclohexyl derivatives as e-selectin antagonistsGLYCOMIMETICS INC·Filed 2021·Granted Jan 23, 2024·0 cites·29 claims
- 2873US6916819B2Benzimidazole and pyridylimidazole derivativesNEUROGEN CORP·Filed 2001·Granted Jul 12, 2005·5 cites·95 claims
- 2973US5656762A4-piperidino-and piperazinomethyl-2-phenylimidazole derivatives, dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Aug 12, 1997·9 cites·5 claims
- 3072US7081458B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2005·Granted Jul 25, 2006·1 cites·31 claims
- 3172US2024150388A1Heterobifunctional inhibitors of e-selectin and galectin-3GLYCOMIMETICS INC·Filed 2023·Application pending·0 cites
- 3266US5646281ACertain 4-piperidino- and piperazinomethyl-2-phenyl imidazole derivatives; dopamine receptor subtype specific ligandsNEUROGEN CORP·Filed 1995·Granted Jul 8, 1997·6 cites·4 claims
- 3357US2023364277A1E-selectin targeting agentsGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 3457US2024417420A1Polar cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3556US7241765B2Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analoguesNEUROGEN CORP·Filed 2006·Granted Jul 10, 2007·0 cites·44 claims
- 3655US2024270724A1Galectin-3 inhibiting c-glycosidesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3755US2024287121A1Galectin-3 inhibiting c-glycoside oximesGLYCOMIMETICS INC·Filed 2022·Application pending·0 cites
- 3854US2007249616A1Substituted 1-Benzyl-4-Substituted Piperazine AnaloguesNEUROGEN CORP·Filed 2007·Application pending·0 cites
- 3953US7008947B2(Oxo-pyrazolo[1,5a]pyrimidin-2-yl)alkyl-carboxamidesNEUROGEN CORP·Filed 2004·Granted Mar 7, 2006·0 cites·66 claims
- 4053US2023167150A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4153US2023167149A1Cd33 ligands suitable for incorporation into carriersGLYCOMIMETICS INC·Filed 2021·Application pending·0 cites
- 4252US2011230497A1Biologically active amidesLUNDBECK & CO AS H·Filed 2009·Application pending·0 cites
- 4351US5985873ACertain substituted benzylamine derivatives a new class of Neuropeptide-Y1 specific ligandsNEUROGEN CORP·Filed 1997·Granted Nov 16, 1999·9 cites·25 claims
- 4451US2022220144A1Multimeric pan-selectin antagonistsGLYCOMIMETICS INC·Filed 2020·Application pending·0 cites
- 4549US2023079833A1Galactose-linked multimeric glycomimetic inhibitors of e-selectins, galectin-3, and/or cxcr4 chemokine receptorsGLYCOMIMETICS INC·Filed 2020·Application pending·0 cites
- 4647US2023091472A1Galectin-3 inhibiting c-glycoside ketones, ethers, and alcoholsGLYCOMIMETICS INC·Filed 2020·Application pending·0 cites
- 4745US2002151550A1Aryl and heteroaryl fused aminoalkyl-imidazole derivatives: selective modulators of bradykinin B2 receptorsNEUROGEN CORP·Filed 2002·Application pending·0 cites
- 4844US11548908B2Heterobifunctional inhibitors of E-selectin and galectin-3GLYCOMIMETICS INC·Filed 2018·Granted Jan 10, 2023·0 cites·92 claims
- 4944US2006154917A1Substituted (heterocycloalkyl)methyl azole derivatives as c5a receptor modulatorsNEUROGEN CORP·Filed 2004·Application pending·0 cites
- 5044US2015284420A1E-selectin antagonist compounds and methods of useGLYCOMIMETICS INC·Filed 2013·Application pending·0 cites
Showing the top 50 of 62 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when John M. Peterson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →